Skip to main content

Table 4 Five- and 10-year observed and relative survival of GIST according to risk of malignant behavior classifications

From: Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study

 

Time (years)

N at risk

OS (95% confidence interval)

RS (95% confidence interval)

All cases (N = 132)

    
 

5

84

62.9 (55.2 to 71.7)

69.7 (61.1 to 79.5)

 

10

41

52.8 (44.6 to 62.5)

66.0 (55.8 to 78.0)

Fletcher et al. classification

    

LR

5

34

82.5 (71.5 to 95.2)

88.1 (76.4 to 101.6)

 

10

19

73.6 (60.7 to 89.3)

88.4 (72.9 to 107.2)

IR

5

22

75.0 (60.6 to 92.9)

89.1 (70.2 to 113.1)

 

10

12

71.1 (56.0 to 90.2)

81.8 (66.1 to 101.3)

HR

5

28

56.2 (42.8 to 72.2)

63.0 (49.1 to 80.9)

 

10

11

39.1 (26.9 to 57.0)

49.0 (33.6 to 71.3)

Met

5

2

8.3 (1.3 to 54.4)

9.0 (1.4 to 58.6)

AFIP classification

    

LR

5

46

83.3 (74.0 to 93.9)

91.5 (81.2 to 103.1)

 

10

26

74.4 (63.2 to 87.6)

90.7 (77.1 to 106.8)

IR

5

14

61.9 (44.3 to 86.6)

69.2 (49.5 to 96.8)

 

10

7

55.0 (36.6 to 82.7)

70.5 (46.9 to 106.0)

HR

5

24

56.1 (42.8 to 73.5)

62.1 (47.3 to 81.4)

 

10

9

38.2 (24.9 to 58.6)

46.1 (30.1 to 70.7)

Met

5

2

8.3 (1.3 to 54.4)

9.0 (1.4 to 58.6)

  1. LR, low risk (includes very low risk); IR, intermediate risk; HR, high risk; Met, diagnosed in metastatic disease.